Analyzing biomarkers and risk factors for Alzheimer's disease
Project 2: Biomarker Analysis, Non-Genetic Risk Factors, and Their Genetic Interactions
This study is looking at blood tests to help doctors better diagnose and treat Alzheimer's disease, making sure that people from different backgrounds are included so that everyone can benefit from new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10878686 on NIH RePORTER |
What this research studies
This research focuses on improving the diagnosis and treatment of Alzheimer's disease (AD) by analyzing blood biomarkers that reflect AD pathology. The project aims to ensure that diverse populations are included in clinical trials, which is crucial for developing effective treatments. By studying plasma proteins associated with AD, the research seeks to establish reliable diagnostic thresholds that can be applied across different ethnic groups. This approach also considers non-genetic risk factors that may contribute to AD, enhancing our understanding of the disease's prevention and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from diverse ethnic backgrounds who are at risk for Alzheimer's disease or have early symptoms of cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any risk factors for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of Alzheimer's disease, ultimately improving treatment outcomes for patients.
How similar studies have performed: Previous studies have shown promise in using blood biomarkers for Alzheimer's diagnosis, but this research aims to expand those findings to include diverse populations, making it a novel approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Yokoyama, Jennifer S — University of Pennsylvania
- Study coordinator: Yokoyama, Jennifer S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.